[en] BACKGROUND: Hypomelanosis of Ito is a rare genetic disorder characterized by whorled areas of hypomelanosis. The purpose of the present study was to revisit some aspects of Ito's hypomelanosis. METHODS: Clinical observations included ultraviolet-light-enhanced visualization (ULEV) method. Histochemistry, immunohistochemistry, and electron microscopy were performed on biopsy samples from the hypopigmented areas and the surrounding skin. RESULTS: Both the ULEV and microscopic examinations revealed the heterogeneity of the pigmentation. Hypomelanosis was characterized by a reduction in melanosomes, both in melanocytes and keratinocytes. These organelles were immature and atypical, showing a weak tyrosinase immunoreactivity. Melanosome macroautophagy was prominent in keratinocytes. Some clusters of the same cells exhibited strong immunoreactivity for the Mac 387 antibody (Ca(2+) -dependent calprotectin). Ulex europaeus agglutinin-1 (UEA-1) decorated the superficial layers of the epidermis. Such features are typically found in functionally altered keratinocytes. A number of dermal cells exhibited intense phagocytic activity linked to lysozyme immunoreactivity. CONCLUSIONS: Both the melanosome depletion and macroautophagy of immature melanosomes in keratinocytes appeared to represent prominent aspects of hypomelanosis of Ito. In sum, Ito's hypomelanosis combines structural and functional changes affecting both the melanocytes and keratinocytes in the skin.
Disciplines :
Dermatologie
Auteur, co-auteur :
Devillers, Céline
QUATRESOOZ, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Hermanns-Lê, Trinh ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Ruiz-Maldonado R, Toussain S, Tamayo L, et al. Hypomelanosis of Ito: diagnostic criteria and report of 41 cases. Pediatr Dermatol 1992; 9: 1-10.
Cellini A, Morroni M, Simonetti O, Offinadi A. Hypomelanosis of Ito: a case report with clinical and ultrastructural data. J Eur Acad Dermatol Venereol 1998; 10: 73-76.
Pascual-Castroviejo I, Roche C, Martinez-Bermejo A, et al. Hypomelanosis of Ito. A study of 76 infantile cases. Brain Dev 1998; 20: 36-43.
Ruggieri M, Pavone L. Hypomelanosis of Ito: clinical syndrome or just phenotype? J Child Neurol 2000; 15: 635-644.
Gomez-Lado C, Eiris-Pfunal J, Blanco-Barca O, et al. Hypomelanosis of Ito. A possibly under-diagnosed heterogeneous neurocutaneous syndrome. Rev Neurol 2004; 38: 223-228.
Taibjee SM, Bennett DC, Moss C. Abnormal pigmentation in hypomelanosis of Ito and pigmentary mosaicism: the role of pigmentary genes. Br J Dermatol 2004; 151: 269-282.
Keng WT, Harewood L, Grace E, et al. A balanced reciprocal translocation in a case of hypomelanosis of Ito with confirmation of mosaicism using buccal cell interphase FISH. Am J Med Genet A 2006; 140: 1111-1113.
Quatresooz P, Petit L, Uhoda I, et al. Mosaic subclinical melanoderma: an Achilles heel for UV-related epidermal carcinogenesis. Int J Oncol 2004; 25: 1763-1767.
Xhauflaire-Uhoda E, Hermanns JF, Piérard-Franchimont C, Piérard GE. Highlighting the rim of perifollicular epidermal unit. Eur J Dermatol 2006; 16: 225-229.
Hermanns JF, Hermanns-Lê T, Piérard GE. Faint innate hypomelanotic spotting in black skin. Eur J Dermatol 2007; 17: 352-353.
Quatresooz P, Piérard GE. The Visioscan-driven ULEV and SELS methods. In: Barrel AO, Paye M, Maibach HI, eds. Handbook of Cosmetic Science and Technology, 3rd edn. New York, USA: Informa Healthcare, 2009: 283-290.
Lipsker D, Lenormand C. Classification of polygenic inflammatory diseases distributed along the lines of Blaschko. Dermatology 2009; 219: 99-101.
Ito S. Melanins seem to be everywhere in the body, but for what? Pigment Cell Melanoma Res 2008; 22: 12-13.
Yamaguchi Y, Brenner M, Hearing V. The regulation of skin pigmentation. J Biol Chem 2007; 282: 27557-27561.
Sharlow E, Pane C, Eisinger M, et al. The protease-activated receptor-2 upregulates keratinocytes phagocytosis. J Cell Sci 2000; 113: 3093-3101.
Seiberg M, Paine C, Sharlow E, et al. Inhibition of melanosome transfer results in skin lightening. J Invest Dermatol 2000; 115: 162-167.
Seiberg M, Paine C, Sharlow E, et al. The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions. Exp Cell Res 2000; 254: 25-32.
Seiberg M. Keratinocyte-melanocyte interactions during melanosomes transfer. Pigment Cell Res 2001; 14: 236-242.
Thong HY, Jee SH, Sun CC, et al. The patterns of melanosome distribution in keratinocytes of human skin as one determining factor of skin colour. Br J Dermatol 2003; 149: 498-505.
Barral DC, Seabra MC. The melanosome as a model to study organelle motility in mammals. Pigment Cell Res 2004; 17: 111-118.
Santiago-Walker A, Li L, Haass NK, Herlyn M. Melanocytes: from morphology to application. Skin Pharmacol Physiol 2009; 22: 114-121.
Cavallari V, Ussia AF, Siragusa M, Schepis C. Hypomelanosis of Ito: electron microscopical observations on two new cases. J Dermatol Sci 1996; 13: 87-92.
Palungwachira P, Palungwachira P. Incontinentia pigmenti achromians of Ito: an ultrastructural study. J Med Assoc Thai 2006; 89: 253-257.
Eskelinen EL, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta 2008; 1793: 664-673.
Minwalla L, Zhao Y, Le Poole LC, et al. Keratinocytes play a role in regulating distribution patterns of recipient melanosomes in vitro. J Invest Dermatol 2001; 117: 341-347.
Heng MCY, Levine S, Fine H, et al. Expression of the L-fucose moiety on infrainfundibular follicular keratinocytes of terminal follicles, its decreased expression on vellus and indeterminate follicles of androgenetic alopecia, and re-expression in drug-induced hair regrowth. J Invest Dermatol 1992; 98: 73-78.
Paquet P, Piérard GE. New insights in toxic epidermal necrolysis (Lyell's syndrome). Clinical considerations, pathobiology and targeted treatments revisited. Drug Saf 2010; 33: 189-212.
